SLC10A7

Across TCGA pan-cancer cohorts, SLC10A7 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SLC10A7 data layer compared with 24 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher SLC10A7 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SLC10A7 expression acts as an unfavorable survival marker, although some lineages such as GBM and HNSC show a favorable association.

GBM and HNSC are the cancer types where SLC10A7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	DFS	Quartile	All	0.835	0.239	.020	8	view →
HNSC	DFS	Tertile	IV	0.891	0.287	.013	7	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SLC10A7–GBM (DFS)

Open the GBM breakdown →